Matrix metalloproteinases and membrane damage markers in sera of patients with acute myocardial infarction

Molecular and Cellular Biochemistry

Volumn 350, Issue 1-2, 2011, Pages 163-168

  Gopcevic, Kristina ^a   Rovcanin, Branislav ^a   Kekic, Dusan ^a   Radenkovic, Sandra ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b National Cancer Research Center   (Serbia)

Author keywords

Acute myocardial infarction; Deoxyribonuclease I; Gelatinases A and B; Lactate dehydrogenase; Malate dehydrogenase

Indexed keywords

DEOXYRIBONUCLEASE I; GELATINASE A; GELATINASE B; LACTATE DEHYDROGENASE; MALATE DEHYDROGENASE;

ACUTE HEART INFARCTION; AGED; ARTICLE; CARDIAC PATIENT; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANE DAMAGE; PROTEIN ANALYSIS; SPECTROPHOTOMETRY; ZYMOGRAPHY;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL MEMBRANE; DEOXYRIBONUCLEASE I; FEMALE; HUMANS; ISOENZYMES; L-LACTATE DEHYDROGENASE; MALATE DEHYDROGENASE; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; MYOCARDIAL INFARCTION; SEVERITY OF ILLNESS INDEX;

EID: 79953676567     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0694-0     Document Type: Article

References (37)

1. Kumar A, Sivakanesan R, Singh S (2008) Oxidative stress, endogenous antioxidant and ischemia-modified albumin in normolipidemic acute myocardial infarction patients. J Health Sci 54:482-487
2. Tsujita K, Kaikita T et al (2010) Acute coronary syndrome: initiating factors. Nippon Rinsho 68:607-614
3. Hannson GK (2005) Atherosclerosis and coronary arthery disease. N Eng J Med 352:1685-1695
4. Jacobson MD (1996) Reactive oxygen species and programmed cell death. Trends in Biochem Sci 243:81-119
5. Caroll CE (1987) Oxygen free radicals and human disease. Ann Int Med 107:526-545
6. Thygesen K, Alpert JS et al (2007) Universal definition of myocardial infarction. Circulation 116:2634-2653 (Pubitemid 350182388)
7. Lo AS, Liew CT et al (2005) Developmental regulation and cellular distribution of human cytosolic malate dehydrogenase. J Cell Biochem 94:763-773 (Pubitemid 41420274)
8. Lewis DG, Wei R et al (2008) Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest 118:3503-3512
9. Kawai Y, Yoshida M et al (2004) Diagnostic use of serum deoxyribonuclease I activity as a novel early-phase marker in acute myocardial infarction. Circulation 109:2398-2400 (Pubitemid 38679557)
10. Giannitsis E, Katus HA (2007) Ability of DNase I activity to detect myocardial ischemia in vasospastic angina - a view through a monocle? Eur Heart J 28:2955-2956
11. Morikawa N, Kawai Y et al (2007) Serum deoxyribonuclease I activity can be used as a novel marker of transient myocardial ischaemia: results in vasospastic angina pectoris induced by provocation test. Eur Heart J 28:2992-2997 (Pubitemid 350262261)
12. Agewall S (2006) Matrix metalloproteinases and cardiovascular disease. Eur Heart J 27:121-122
13. Hayashidani S, Tsutsui H et al (2003) Targeted deletion of MMP- 2 attenuates early LV rupture and left remodeling after experimental myocardial infarction. Am J Physiol Heart Circ Physiol 285:H1229-H1235 (Pubitemid 37048181)
14. Matsumara S, Iwanaga S et al (2005) Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J Clin Invest 115:599-609 (Pubitemid 40322234)
15. Heymans S, Luttun A et al (1999) Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5:1135-1142 (Pubitemid 29474417)
16. Romanic AM, Harrison SM et al (2002) Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9. Cardiovas Res 54:549-558 (Pubitemid 34595413)
17. Kai H, Ikeda H et al (1998) Peripheral blood levels of matrix metalloproteinases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 32:368-372 (Pubitemid 28396484)
18. Nagase H, Visse R, Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69:562-573 (Pubitemid 43139720)
19. Jones CB, Sane DC, Herrington DM (2003) Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovasc Res 59:812-823 (Pubitemid 38366237)
20. Buhl SN, Jackson KY et al (1977) Optimal conditions for assaying human lactate dehydrogenase by the lactate-to-pyruvate reaction: Arrhenius relationships for lactate dehydrogenase isoenzymes 1 and 5. Gun Chem 23:1289
21. Frieden CJ, Fernandez S (1975) Kinetic studies on pig heart cytoplasmic malate dehydrogenase. J Biol Chem 250:2106-2113
22. Kunitz M (1950) Isolation and general properties spectrophotometric method for the measurement of DNase activity. J Gen Phys 33:349-362
23. Van der Helm HJ (1962) Interference of the measurement of lactate dehydrogenase (LDH) activity in human serum and plasma by LDH from blood cells. Clin Chem Acta 7:124-128
24. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
25. Yoshimura Y, Kawano T et al (1970) Zymographic demonstration of lactate and malate dehydrogenases isoenzymes in the rodent salivary glands. Histochem Cell Biol 22:337-346
26. La Rocca G, Pucci MI et al (2004) Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. Br J Cancer 90:1414-1421 (Pubitemid 38586271)
27. Rotenberg Z, Weinberger I et al (1987) Lactate dehydrogenase isoenzymes in serum during recent acute myocardial infarction. Clin Chem 33:1419-1420 (Pubitemid 18041982)
28. Wagenknecht K, Barleben H et al (1988) Malate dehydrogenase isoenzymes in myocardial infarction. Kardiologiia 28:55-57
29. Yao M, Koegh A et al (1996) Elevated DNase I levels in human idiopathic dilated cardiomyopathy: an indicator of apoptosis? J Mol Cell Cardiol 28:95-101 (Pubitemid 26110455)
30. Massova I, Kotra LP et al (1998) Matrix metalloproteinases: structures, evolution and diversification. FASEB J 12:1075-1095 (Pubitemid 28418938)
31. Noji Y, Kajinami K et al (2001) Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis. Clin Chem Lab Med 39:380-384 (Pubitemid 32529917)
32. Zempo N, Kenargy RD et al (1994) Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J Vasc Surg 20:209-217 (Pubitemid 24260589)
33. Celik T, Iyisoy A et al (2008) Matrix metalloproteinases in acute coronary syndromes: a new therapeutic target? Int J Cardiol 134:402-404
34. Armstrong EJ, Morrow DA et al (2006) Inflammatory biomarkers in acute coronary syndromes: part IV: matrix metalloproteinases and biomarkers of platelet activation. Circulation 113:382-385
35. Fukuda D, Shimada K et al (2006) Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris. Am J Cardiol 97:175-180 (Pubitemid 43139231)
36. Konstantino Y, Nguyen TT et al (2009) Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery disease. Biomarkers 14:118-129
37. Moe KT, Wong P (2010) Current trends in diagnostic biomarkers of acute coronary syndrome. Ann Acad Med Singapore 39:210-215